Jurisprudence Examination Practice Exam
2026/2027 — Connecticut Pharmacy Law
and Federal Pharmacy Law | Exam-Style
MCQs with Correct Answers & Detailed
Rationales |
1. A Connecticut pharmacist is reviewing the scope of
practice for a pharmacy technician. Which activity is
generally permissible for a registered pharmacy
technician when performed under the required
pharmacist supervision?
A. Independently determining whether a prescription is
clinically appropriate
B. Counseling a patient about adverse effects of a newly
prescribed medication
C. Entering prescription information into the pharmacy's
computer system
D. Authorizing a therapeutic interchange without pharmacist
approval
Correct Answer: C
Entering prescription information is a technical function that
may be performed by a properly registered technician under
pharmacist supervision. Clinical judgment, patient
counseling, and authorization of therapeutic decisions remain
pharmacist responsibilities; therefore, A, B, and D require
,pharmacist judgment and are not appropriate independent
technician functions.
2. A Connecticut pharmacist receives a prescription that
contains an obvious dosage error. The prescriber is
immediately reachable. What is the pharmacist's best
course of action?
A. Dispense the prescription exactly as written because the
prescriber issued it
B. Correct the dosage independently and dispense it
C. Contact the prescriber to clarify the prescription before
dispensing
D. Ask the technician to determine the intended dosage
Correct Answer: C
The pharmacist has a professional duty to evaluate a
prescription for appropriateness and should clarify a
potentially dangerous error with the prescriber before
dispensing. A is inappropriate because a prescriber's order
does not eliminate the pharmacist's responsibility to identify
significant medication problems, while B would improperly
substitute the pharmacist's judgment for the prescriber's
intended order.
3. Which statement best describes the purpose of
Connecticut's Prescription Monitoring Program?
,A. To replace the pharmacist's professional judgment
regarding controlled substances
B. To collect and provide information concerning controlled-
substance dispensing
C. To authorize pharmacists to prescribe controlled substances
D. To determine whether a patient is financially eligible for
controlled substances
Correct Answer: B
The prescription monitoring program is designed to collect
and make available dispensing information involving
controlled substances and other medications covered by the
program. It supports identification of potential misuse,
duplicate therapy, and other prescribing or dispensing
concerns, but it does not replace professional judgment or
grant prescribing authority.
4. A pharmacist discovers that a controlled substance
prescription appears to have been altered after issuance.
What is the most appropriate initial action?
A. Dispense it because the patient possesses the original
prescription
B. Ignore the alteration if the medication and quantity appear
reasonable
C. Verify the prescription with the prescriber before
dispensing
D. Change the prescription back to what the pharmacist
believes was intended
, Correct Answer: C
An apparent alteration creates a significant authenticity
concern, so the pharmacist should verify the prescription with
the prescriber before dispensing. A and B fail to address the
possibility of forgery or unauthorized modification, while D
improperly permits the pharmacist to reconstruct a
prescription rather than obtain confirmation.
5. Which federal law primarily establishes the five
schedules of controlled substances and regulates their
manufacture, distribution, dispensing, and possession?
A. Controlled Substances Act
B. Health Insurance Portability and Accountability Act
C. Food, Drug, and Cosmetic Act
D. Poison Prevention Packaging Act
Correct Answer: A
The Controlled Substances Act establishes the federal
scheduling framework and provides the principal federal
controls governing controlled substances. HIPAA primarily
addresses protected health information, the Food, Drug, and
Cosmetic Act addresses drugs and related products more
broadly, and the Poison Prevention Packaging Act concerns
packaging requirements.
6. A Schedule II prescription is presented to a pharmacist.
The patient asks the pharmacist to telephone the